Magnetic resonance imaging in inflammatory bowel disease.
Magnetic resonance (MR) images were acquired in 28 consecutive inflammatory bowel disease (IBD) patients undergoing medical treatment. The protocol employed included i.v. gadopentatate dimeglumine, pre- and post-contrast breath-hold Fast Low Angle Shot (FLASH), and fat-suppressed spin echo imaging. The percent contrast enhancement (% CE) of the fat-suppressed images was compared with severity of inflammation based on endoscopic and/or surgical findings. The %CE of the contrast-enhanced images was 169% +/- 63 in cases of severe inflammation (n = 16), 97% +/- 38 in moderate inflammation (n = 8), and 49% +/- 26 in mild inflammation (n = 4). Significant correlations were found between the clinicopathologic findings and (a) % CE, r = 0.74 (p = 0.0001); (b) length of affected bowel segment, r = 0.49 (p = 0.007); and (c) bowel wall thickness, r = 0.42 (p = 0.02). In a subsequent comparison, %CE was correlated with length of affected bowel and bowel wall thickness. The best correlation was bowel wall thickness, r = 0.53 (p < 0.004). Good correlation was found between MR findings and pathology/histology findings in the determination of bowel wall thickness, length of diseased bowel, and severity of inflammation in 10 patients who underwent bowel resection. The results of this study show that MR images demonstrate the extent and severity of inflammatory changes in the GI tract, which correlate with endoscopic and histological findings.